{
    "Trade/Device Name(s)": [
        "Alc GEAR System"
    ],
    "Submitter Information": "SAKAE CORPORATION",
    "510(k) Number": "K130014",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071466"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JJE"
    ],
    "Summary Letter Date": "April 4, 2014",
    "Summary Letter Received Date": "March 31, 2014",
    "Submission Date": "March 28, 2014",
    "Regulation Number(s)": [
        "21 CFR 864.7470",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Discrete photometric chemistry analyzer for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c (%HbA1c)"
    ],
    "Specimen Type(s)": [
        "Finger-stick whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Sodium fluoride (NaF) tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Alc GEAR System",
        "Alc GEAR instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Immuno-turbidimetric",
        "Photometric analysis"
    ],
    "Methodologies": [
        "Immunoassay",
        "Spectrophotometry"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Reagent",
        "Cartridge",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for SAKAE CORPORATION Alc GEAR System for quantitative measurement of hemoglobin A1c in human whole blood using immuno-turbidimetric spectrophotometry.",
    "Indications for Use Summary": "For in vitro diagnostic use for the quantitative measurement of percent hemoglobin A1c (%HbA1c) from finger-stick or venous whole blood collected in EDTA or sodium fluoride, to monitor long-term glycemic control in patients previously diagnosed with diabetes mellitus; not for screening or diagnosis of diabetes.",
    "fda_folder": "Hematology"
}